RF Bio

RF Bio, a subsidiary of RF Tech, held a groundbreaking ceremony on October 28, 2022, for a new plant in Wonju, South Korea, to produce hyaluronic acid fillers and botulinum toxin. The company is investing approximately KRW 33.1 billion (USD 23 million) in the facility, which is expected to be completed by December 2023 and will increase production capacity fivefold by 2024.